Date: Mon, 27 Sep 2004 16:28:38 -0400
From: customer service mailbox <customerservice@idefense.com.>
To: [email protected], [email protected]Subject: iDEFENSE Security Advisory 09.27.04 - IBM AIX ctstrtcasd Local File Corruption Vulnerability
IBM AIX ctstrtcasd Local File Corruption Vulnerability
iDEFENSE Security Advisory 09.27.04
www.idefense.com/application/poi/display?id=3D144&type=3Dvulnerabilities
September 27, 2004
I. BACKGROUND
The ctstrtcasd program is a setuid root application, installed by=20
default under newer versions of IBM AIX. It is part of the Reliable=20
Scalable Cluster Technology (RSCT) system. It is also installed with=20
multiple IBM products under Linux, including IBM Tivoli System=20
Automation, IBM Cluster Systems Management, IBM Hardware Management=20
Console, and IBM General Parallel File System.
II. DESCRIPTION
Local exploitation of an input validation vulnerability in the
ctstrtcasd command included by default in multiple versions of IBM Corp.
AIX could allow for the corruption or creation of arbitrary files
anywhere on the system.
If a user specifies a file with the -f option, the contents of that file
will be overwritten with 65,535 bytes of application trace data. If the
file doesn't exist, it will be created. The file creation/overwrite is
done with root privileges, thus allowing an attacker to cause a denial
of service condition by damaging the file system or by filling the drive
with 65,535 byte files.
III. ANALYSIS
All that is required to exploit this vulnerability is a local account.=20
Exploitation does not require any knowledge of application internals,
making exploitation trivial, even for unskilled attackers. It
is not evident that privilege escalation is possible through abuse of
this.
IV. DETECTION
iDEFENSE has confirmed the existence of this vulnerability in IBM AIX=20
5.2. IBM has reported that RSCT versions 2.3.0.0 and greater are=20
affected, for AIX 5.2 and 5.3 on pSeries; AIX on i5/OS (iSeries); RSCT=20
on Linux (pSeries, xSeries, zSeries), and the pSeries Hardware=20
Management Console. Products shipping and installing these affected
versions of RSCT as reported by IBM are as follows:
=20
IBM AIX 5L Version 5.2 on pSeries
IBM AIX 5L Version 5.3 on pSeries
IBM AIX 5L Version 5.2, 5.3 on an i5/OS (iSeries) partition
IBM Tivoli System Automation (TSA) for Linux 1.1
IBM Tivoli System Automation (TSA) for Multiplatforms 1.2
IBM Cluster Systems Management (CSM) for Linux Version 1.4
(version 1.4 and greater)
IBM Hardware Management Console (HMC) for pSeries Version 3
IBM Hardware Management Console (HMC) for pSeries Version 4
IBM General Parallel File System (GPFS) Version 2 Release 2
on Linux for xSeries and Linux for pSeries=20
V. WORKAROUND
Only allow trusted users local access to security critical systems.
Alternately, remove the setuid bit from ctstrtcasd using chmod 555
/usr/sbin/rsct/bin/ctstrtcasd.
VI. VENDOR RESPONSE
"Apply the workarounds or APARs as described [in the associated IBM
Security Alert].
If you would like to receive AIX Security Advisories via email, please
visit:
https://techsupport.services.ibm.com/server/pseries.subscriptionSvcs"
VII. CVE INFORMATION
The Common Vulnerabilities and Exposures (CVE) project has assigned the
names CAN-2004-0828 to these issues. This is a candidate for inclusion
in the CVE list (http://cve.mitre.org), which standardizes names for
security problems.
=20
VIII. DISCLOSURE TIMELINE=20
=20
08/11/2004 Initial vendor notification
08/25/2004 Secondary vendor notification
08/26/2004 Vendor response=20
09/27/2004 Coordinated public disclosure=20
=20
IX. CREDIT=20
=20
iDEFENSE Labs is credited with this discovery.=20
=20
Get paid for vulnerability research
http://www.idefense.com/poi/teams/vcp.jsp
X. LEGAL NOTICES
Copyright (c) 2004 iDEFENSE, Inc.
Permission is granted for the redistribution of this alert
electronically. It may not be edited in any way without the express
written consent of iDEFENSE. If you wish to reprint the whole or any
part of this alert in any other medium other than electronically, please
email [email protected] for permission.
Disclaimer: The information in the advisory is believed to be accurate
at the time of publishing based on currently available information. Use
of the information constitutes acceptance for use in an AS IS condition.
There are no warranties with regard to this information. Neither the
author nor the publisher accepts any liability for any direct, indirect,
or consequential loss or damage arising from use of, or reliance on,
this information.
